Fleisher KE - Search Results

1

Predicting risk for bisphosphonate-related osteonecrosis of the jaws: CTX versus radiographic markers.

Fleisher KE, Welch G, Kottal S, Craig RG, Saxena D, Glickman RS. Fleisher KE, et al. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Oct;110(4):509-16. doi: 10.1016/j.tripleo.2010.04.023. Epub 2010 Jul 31. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010. PMID: 20674404

2

Tetracycline-guided debridement and cone beam computed tomography for the treatment of bisphosphonate-related osteonecrosis of the jaw: a technical note.

Fleisher KE, Doty S, Kottal S, Phelan J, Norman RG, Glickman RS. Fleisher KE, et al. J Oral Maxillofac Surg. 2008 Dec;66(12):2646-53. doi: 10.1016/j.joms.2008.07.021. J Oral Maxillofac Surg. 2008. PMID: 19022151 No abstract available.

3

Osteonecrosis of the jaw onset times are based on the route of bisphosphonate therapy.

Fleisher KE, Jolly A, Venkata UD, Norman RG, Saxena D, Glickman RS. Fleisher KE, et al. J Oral Maxillofac Surg. 2013 Mar;71(3):513-9. doi: 10.1016/j.joms.2012.07.049. Epub 2012 Sep 19. J Oral Maxillofac Surg. 2013. PMID: 22999296

4

Oral microbiota and host innate immune response in bisphosphonate-related osteonecrosis of the jaw.

Pushalkar S, Li X, Kurago Z, Ramanathapuram LV, Matsumura S, Fleisher KE, Glickman R, Yan W, Li Y, Saxena D. Pushalkar S, et al. Among authors: fleisher ke. Int J Oral Sci. 2014 Dec;6(4):219-26. doi: 10.1038/ijos.2014.46. Epub 2014 Aug 8. Int J Oral Sci. 2014. PMID: 25105817 Free PMC article.

5

Comorbid conditions are a risk for osteonecrosis of the jaw unrelated to antiresorptive therapy.

Fleisher KE, Janal MN, Albstein N, Young J, Bikhazi V, Schwalb S, Wolff M, Glickman RS. Fleisher KE, et al. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019 Feb;127(2):140-150. doi: 10.1016/j.oooo.2018.09.012. Epub 2018 Oct 5. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019. PMID: 30449690

6

Antibiotic effects on bacterial profile in osteonecrosis of the jaw.

Ji X, Pushalkar S, Li Y, Glickman R, Fleisher K, Saxena D. Ji X, et al. Oral Dis. 2012 Jan;18(1):85-95. doi: 10.1111/j.1601-0825.2011.01848.x. Epub 2011 Aug 29. Oral Dis. 2012. PMID: 21883710 Free PMC article. Clinical Trial.

7

Risk factors for bisphosphonate-related osteonecrosis of the jaws.

Fleisher KE, Glickman RS. Fleisher KE, et al. J Oral Maxillofac Surg. 2011 Apr;69(4):959; author reply 959-60. doi: 10.1016/j.joms.2010.05.093. J Oral Maxillofac Surg. 2011. PMID: 21440820 No abstract available.

8

Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw.

Fleisher KE, Raad RA, Rakheja R, Gupta V, Chan KC, Friedman KP, Mourtzikos KA, Janal M, Glickman RS. Fleisher KE, et al. J Oral Maxillofac Surg. 2014 Oct;72(10):1957-65. doi: 10.1016/j.joms.2014.04.017. Epub 2014 Apr 24. J Oral Maxillofac Surg. 2014. PMID: 25053572

9

Does Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography Facilitate Treatment of Medication-Related Osteonecrosis of the Jaw?

Fleisher KE, Pham S, Raad RA, Friedman KP, Ghesani M, Chan KC, Amintavakoli N, Janal M, Levine JP, Glickman RS. Fleisher KE, et al. J Oral Maxillofac Surg. 2016 May;74(5):945-58. doi: 10.1016/j.joms.2015.10.025. Epub 2015 Nov 6. J Oral Maxillofac Surg. 2016. PMID: 26657395

10

Protective Measures against COVID-19: Dental Practice and Infection Control.

Induri SNR, Chun YC, Chun JC, Fleisher KE, Glickman RS, Xu F, Ioannidou E, Li X, Saxena D. Induri SNR, et al. Among authors: fleisher ke. Healthcare (Basel). 2021 Jun 4;9(6):679. doi: 10.3390/healthcare9060679. Healthcare (Basel). 2021. PMID: 34200036 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page